AI
Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Sempre Health Raises $15M In Series B Financing To Improve Medication Affordability
06/15/21, 11:42 AM
Location
san francisco
Money raised
$15 million
Round Type
series b
Sempre Health, the leading solution for behavior-based healthcare pricing, announced today the closing of $15M in Series B financing. The funding round was led by the Blue Venture Fund - a unique collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox, to which thirty-five BCBS companies have committed over $890 million across four funds. UPMC Enterprises and existing investors Rethink Impact, LifeForce Capital and Industry Ventures also participated. This round of funding will be used to advance Sempre's two-sided network of payors and pharma manufacturers nationwide and further grow the number of chronic disease patients Sempre can help better afford and access their medications
Company Info
Location
san francisco, california, united states
Additional Info
Sempre Health works with leading health plans and pharmaceutical companies to reduce out-of-pocket costs for patients who refill their prescriptions on time. By combining technology, behavioral science, and dynamic pricing, Sempre Health aims to boost all of its members' medication adherence to exceed 80 percent of days covered -- the widely acknowledged gold standard. Doing so will dramatically improve the health of millions of people and save hundreds of billions of dollars in avoidable medical costs. For more information visit: www.semprehealth.com.
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.